The DZD DiaMet Biobank as a key research infrastructure
Biobanks provide a vital foundation for research into diabetes and its complications by making high-quality research data and biological samples available for scientific studies. The advisory board members gained a comprehensive insight into biobanking, with a particular focus on the DZD DiaMet Biobank. The presentation covered the key processes involved in sample and data collection, as well as the fundamental framework conditions for collection and the governance structures governing the use of data and biological samples in research.
In the constructive discussion that followed, the participants explored how to enhance public understanding of biobanks. Together, they identified which information is particularly important to the public and through which communication channels it can best be shared. It became clear that transparent communication, understandable information, and a clear presentation of the concrete benefits for research are crucial for building trust and strengthening the public’s willingness to support scientific projects.
Further development of the DZD study participant management system
Another focus of the meeting was the presentation of a concept for the planned DZD study participant management system. The project is based on recommendations and suggestions that the Advisory Board has put forward in recent meetings. Measures to improve the recruitment of study participants were presented, as well as approaches to encourage long-term participation in clinical studies. The members of the Advisory Board discussed the proposed concept and the specific measures from the perspective of patients and citizens and offered further suggestions for a user-friendly design. In addition, the board reviewed a draft flyer for new DZD clinical studies and provided recommendations for clear and target-group-appropriate messaging.
Recommendation on the early detection of type 1 diabetes
The Advisory Board also adopted the recommendation titled “Raising Awareness About Screening Options for the Early Diagnosis of Type 1 Diabetes in Children in Germany.” With this initiative, the board aims to help raise awareness of the warning signs of type 1 diabetes and provide information about existing options for early detection, including those available through the Fr1da study.
Expanding patient and citizen participation
The DZD provided information on current developments and research findings, as well as news from the German Centers for Health Research (DZG). Looking ahead to the coming years, the Advisory Board discussed its future development. Plans include recruiting new members for the CAB and establishing a pool of patient experts. This pool is intended to enable in-depth exploration of specific topics in the future.
With its tenth meeting, the DZD Patients' and Citizens' Advisory Board underscores the importance of ongoing dialogue between researchers, patients, and the public. The discussion on biobanking, in particular, highlighted how crucial transparent communication and active participation are for fostering understanding of innovative research infrastructures and jointly shaping the future of diabetes research.
